European Archives of Oto-Rhino-Laryngology

, Volume 270, Issue 4, pp 1507–1512

Multicenter evaluation of Neurelec Digisonic® SP cochlear implant reliability

  • Luminiţa Rădulescu
  • Sebastian Cozma
  • Casimir Niemczyk
  • Nicolas Guevara
  • Ivan Gahide
  • John Economides
  • Jean-Pierre Lavieille
  • Renaud Meller
  • Jean-Pierre Bébéar
  • Emilien Radafy
  • Philippe Bordure
  • Djamel Djennaoui
  • Eric Truy
Miscellaneous

DOI: 10.1007/s00405-012-2266-2

Cite this article as:
Rădulescu, L., Cozma, S., Niemczyk, C. et al. Eur Arch Otorhinolaryngol (2013) 270: 1507. doi:10.1007/s00405-012-2266-2

Abstract

Over the past decade, the adoption of universal hearing screening in newborns has led to earlier detection of hearing problems and significant lowering of the age of first cochlear implantation. As a consequence, recipients are now expected to keep their cochlear implants (CIs) for a longer period of time. Comprehensive longitudinal information on CI reliability is essential for device choice. The aim of this study was to assess the reliability (in children and adults) of the latest generation of the Digisonic® SP CI launched in 2006 by Neurelec. Failure rate (FR) and cumulative survival rate (CSR) for a 5-year period were calculated. This survey is a multicenter retrospective study. A questionnaire was sent to nine CI centers requesting information about patients implanted with Neurelec Digisonic® SP CIs. FR and CSR over a 5-year period were calculated on this group. Collaborating centers collected data on 672 patients (362 children and 310 adults) implanted between March 2006 and March 2011. The overall rate of explantation was 2.23 % (15 cases): six devices were explanted due to device failure (0.89 %) and nine were explanted for medical reasons (1.34 %). Four patients were lost to follow-up. The CSR at 5 years was 98.51 % on all patients, 98.48 % for children and 98.57 % for adults. FR was 0.97 % for adults and 0.83 % for children. This first independent study that assesses FR and CSR on the current generation of Digisonic® SP CI represents an important resource that can help clinicians and patients during their device choice.

Keywords

Failure rateCumulative survival rateReliabilityCochlear implant

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Luminiţa Rădulescu
    • 1
  • Sebastian Cozma
    • 1
  • Casimir Niemczyk
    • 2
  • Nicolas Guevara
    • 3
  • Ivan Gahide
    • 3
  • John Economides
    • 4
  • Jean-Pierre Lavieille
    • 5
  • Renaud Meller
    • 5
  • Jean-Pierre Bébéar
    • 6
  • Emilien Radafy
    • 7
  • Philippe Bordure
    • 7
  • Djamel Djennaoui
    • 8
  • Eric Truy
    • 9
    • 10
  1. 1.ENT Department, Rehabilitation HospitalUniversity of Medicine and Pharmacy “Gr. T. Popa”IasiRomania
  2. 2.ENT DepartmentUniversity Hospital BanachaWarsawPoland
  3. 3.ENT DepartmentPasteur HospitalNiceFrance
  4. 4.ENT DepartmentGeneral Children’s Hospital Aghia SophiaAthensGreece
  5. 5.ENT DepartmentNord HospitalMarseilleFrance
  6. 6.ENT DepartmentPellegrin Hospital, University of BordeauxBordeauxFrance
  7. 7.ENT DepartmentUniversity Hospital NantesNantesFrance
  8. 8.ENT DepartmentUniversity Hospital MustafaAlgerAlgeria
  9. 9.ENT DepartmentEdouard Herriot University Hospital, Hospices Civils de LyonLyonFrance
  10. 10.INSERM U1028–CNRS UMR5292, Lyon Neuroscience Research CenterBrain Dynamics and Cognition Team, University of LyonLyonFrance